Effect of acute consumption of legumes with different processing on post-prandial glycaemic profile

King Abdulaziz University0 个研究点目标入组 19 人开始时间: 2019年7月1日最近更新: 2022年2月7日

适应症

试验速览

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35024710/ (added 24/01/2022)

•1. Regular drug therapy
•2. Diabetes (fasting glucose >126 mg/dL, or anti-diabetic treatment)
•3. Hypothydroidism or thyroxine treatment
•4. Ill or suffer from any underlying health condition that can affect their ability to taste, smell, chew, digest or excrete of food
•5. History of cancer or cancer treatment
•6. Active or recently diagnosed intestinal malabsorption or disorders associated with malabsorption: Crohn’s disease, short bowel syndrome, Pancreatic insufficiency, cystic fibrosis, Tropical Sprue, whipple’s disease, chronic pancreatitis, gastrojejunostomy, surgical treatments for obesity, cholestasis, biliary atresia, parasite infections, HIV/AIDS
•7. Use of medication known to cause malabsorption: tetracycline, cholestyramine, thiazide diuretics, aluminium/magnesium hydroxide, colchicine, neomycin, methotrexate, methyldopa, and allopurinol, and laxatives
•8. Illegal drug use or chronic alcoholism
•9. History of allergy or intolerance to any components used in the study
•10. Women who are pregnant, lactating or actively trying to conceive
•11. Participation in other clinical trials that may impact on outcome

发起方